
Rheumatology Drug Updates: Biosiomilar to Adalimumab Receives FDA Approval; plus Updates on Baricitinib, Tofacitinib, Bimekizumab

FDA Responds to New Drug Application for Baricitinib

Biosimilar Drugs Raise Questions around Treatment Efficacy, Quality, Safety

Quality Measures Used to Assess Care, Improve Outcomes in Children, Adults with Rheumatic Diseases

Pain Management Research Sheds Light on Postsurgical Pain Sensitization, Opioid Risks, Nondrug Interventions

Rheumatology Practices Need Sharp Focus on Patient Care Safety, Quality

Tips for Rheumatologists to Master Quality Measurement in Clinical Practice

The ACR’s 2015 Workforce Study Reveals Gap Between Rheumatologist Supply, Patient Demand

Combining Humanities, Clinical Care Essential to Providing Quality Healthcare
- 1
- 2
- 3
- …
- 9
- Next Page »